Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios Pro Rata

Dive into the world of dealmakers across VC, PE and M&A with Axios Pro Rata. Delivered daily to your inbox by Dan Primack and Kia Kokalitcheva.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Nashville news?

Get a daily digest of the most important stories affecting your hometown with the Axios Nashville newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Columbus news?

Get a daily digest of the most important stories affecting your hometown with the Axios Columbus newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Dallas news?

Get a daily digest of the most important stories affecting your hometown with the Axios Dallas newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Austin news?

Get a daily digest of the most important stories affecting your hometown with the Axios Austin newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Atlanta news?

Get a daily digest of the most important stories affecting your hometown with the Axios Atlanta newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Philadelphia news?

Get a daily digest of the most important stories affecting your hometown with the Axios Philadelphia newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Chicago news?

Get a daily digest of the most important stories affecting your hometown with the Axios Chicago newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top DC news?

Get a daily digest of the most important stories affecting your hometown with the Axios DC newsletter.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Illustration: Aïda Amer/Axios

Rapid at-home COVID-19 tests that can automatically verify and report positive cases could be especially useful in the next phase of the pandemic.

Why it matters: As breakthrough cases rise with the inevitable waning of vaccination-induced immunity, cheap, plentiful screening tests that automatically send results back to health authorities could keep infections down while allowing full reopening.

Driving the news: Recent data from the U.K. — one of the first countries to widely vaccinate its population — shows breakthrough COVID cases are growing, particularly among 40- to 49-year-olds who are likely being infected by their still largely unvaccinated children.

  • Because the CDC hasn't recently updated data on breakthrough infections in the U.S., the national picture is fuzzy, but many states that are tracking numbers are seeing a rise.

The big picture: Vaccines are still highly effective against hospitalization and death, but the virus will keep spreading, and inevitable disruptions will follow.

  • A recent Yahoo News/YouGov poll found nearly 4 in 10 parents know children who have been forced to quarantine because of COVID-19 since the start of the school year.

Between the lines: That's where better, more available rapid at-home tests should be playing a bigger role, says Michael Mina, an epidemiologist at the Harvard T.H. Chan School of Public Health.

  • "Quarantines represent an information problem, because they're done when we're not certain an exposed person is positive," he says. "When you have the tools to effectively know who is positive, you don't have to quarantine anyone."
  • "So we should be deploying these rapid tests very strategically."

Details: Only rapid tests can deliver results fast enough to avoid quarantines, and allowing students or workers to take tests at home rather than at school or offices further reduces the chance of infection.

  • Some experts have raised concerns that people might lie about at-home tests results and that results might not make it to health authorities tracking the pandemic, but Mina points to new rapid tests that can automatically verify and report results.
  • eMed provides rapid tests and a virtual guide to help users correctly carry out the tests and authenticate the results, which shows up as a QR code on their smartphone and can be automatically reported back to employers.

The catch: Thanks largely to regulatory hurdles, rapid tests of any kind in the U.S. remain scarce and overpriced, even after billions in additional support from the Biden administration.

The bottom line: Even as deaths and hospitalizations continue to decline, the U.S. could still be in for a winter of disruption without the ability of connected rapid tests to track outbreaks in near real time.

Go deeper

13 hours ago - Health

EU drug regulator backs mixing COVID vaccines

A health worker administers the COVID-19 vaccine at a center outside Rome's Termini railway station in Rome, Italy, on Dec. 3. Photo: Alessia Pierdomenico/Bloomberg via Getty Images

The European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) announced on Tuesday their support for mixing different COVID-19 vaccines in initial vaccinations and booster campaigns.

Why it matters: The announcement comes as several European countries struggle to combat recent surges in COVID-19 cases and amid concerns over the Omicron variant.

Axios-Ipsos poll: Shrugging off Omicron

Expand chart
Data: Axios/Ipsos poll; Note: The last question only includes 589 employed respondents; Chart: Kavya Beheraj/Axios

Most Americans aren't willing to make big changes in their behavior to minimize the risk from the Omicron variant, like avoiding indoor restaurant dining or cancelling their holiday travel plans, according to a new Axios-Ipsos poll.

The big picture: The poll found support for some broader public responses, including one — travel bans aimed at people from other countries — that was widely supported by people across the political spectrum. But it found that Americans are only willing to do so much on their own.

5 hours ago - Health

Report: COVID exacerbated young people's "unprecedented" mental health challenges

Surgeon General Dr. Vivek H. Murthy speaks during a press briefing in the Brady Briefing Room of the White House in Washington, D.C. on July 15. Photo: Saul Loeb/AFP via Getty Images

The U.S. surgeon general warned on Tuesday young people face "unprecedented" mental health challenges — and the pandemic has only made matters worse.

Why it matters: Depression, suicidal ideation and emergency room visits for mental health reasons have risen significantly in young people, according to the 53-page advisory from the country's top physician, Dr. Vivek H. Murthy.